These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10979435)

  • 21. Salivary gland dysfunction: a review of systemic therapies.
    Grisius MM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):156-62. PubMed ID: 11505261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilocarpine for the treatment of salivary glands' impairment caused by radioiodine therapy for thyroid cancer.
    Aframian DJ; Helcer M; Livni D; Markitziu A
    Oral Dis; 2006 May; 12(3):297-300. PubMed ID: 16700739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies.
    Singhal S; Powles R; Treleaven J; Rattenbury H; Mehta J
    Leuk Lymphoma; 1997 Feb; 24(5-6):539-43. PubMed ID: 9086444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug used during radiotherapy helps reduce dry mouth problem.
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):4. PubMed ID: 12113130
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D; Watthanaarpornchai S; Phungrassami T
    J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing salivary gland hypofunction--Part two.
    Muzyka BC
    Pract Proced Aesthet Dent; 2002 Apr; 14(3):262. PubMed ID: 12004635
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
    Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased salivary flow rate as a dipsogenic factor in hemodialysis patients: evidence from an observational study and a pilocarpine clinical trial.
    Sung JM; Kuo SC; Guo HR; Chuang SF; Lee SY; Huang JJ
    J Am Soc Nephrol; 2005 Nov; 16(11):3418-29. PubMed ID: 16177001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral pilocarpine: new preparation. Xerostomia after radiation therapy: moderately effective but costly.
    Prescrire Int; 2002 Aug; 11(60):99-101. PubMed ID: 12199276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late effects of chronic graft-vs.-host disease in minor salivary glands.
    Alborghetti MR; Corrêa ME; Adam RL; Metze K; Coracin FL; de Souza CA; Cintra ML
    J Oral Pathol Med; 2005 Sep; 34(8):486-93. PubMed ID: 16091116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
    Nakamura N; Sasano N; Yamashita H; Igaki H; Shiraishi K; Terahara A; Asakage T; Nakao K; Ebihara Y; Ohtomo K; Nakagawa K
    Auris Nasus Larynx; 2009 Jun; 36(3):310-3. PubMed ID: 18635328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology and management of radiation-induced xerostomia.
    Berk LB; Shivnani AT; Small W
    J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation-induced xerostomia.
    Chambers MS; Rosenthal DI; Weber RS
    Head Neck; 2007 Jan; 29(1):58-63. PubMed ID: 16906511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preserving formerly impaired salivary gland function in radioiodine-treated thyroid papillary carcinoma.
    Aframian DJ; Nahlieli O; Knopf A; Lukach L; Qawasmeh N; Nadler C
    Quintessence Int; 2013 May; 44(5):439-44. PubMed ID: 23479590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new medication for treatment of dry mouth in Sjögren's syndrome.
    al-Hashimi I; Taylor SE
    Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
    Fox RI; Konttinen Y; Fisher A
    Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease--a prolonged study.
    Nagler RM; Nagler A
    Cancer Invest; 2003; 21(1):34-40. PubMed ID: 12643007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilocarpine treatment in a mixed cohort of xerostomic patients.
    Aframian DJ; Helcer M; Livni D; Robinson SD; Markitziu A; Nadler C
    Oral Dis; 2007 Jan; 13(1):88-92. PubMed ID: 17241436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral pilocarpine hydrochloride for the treatment of refractory xerostomia associated with chronic graft-versus-host disease.
    Singhal S; Mehta J; Rattenbury H; Treleaven J; Powles R
    Blood; 1995 Feb; 85(4):1147-8. PubMed ID: 7849306
    [No Abstract]   [Full Text] [Related]  

  • 40. Dental management of xerostomia--opportunity, expertise, obligation.
    Kleinegger CL
    J Calif Dent Assoc; 2007 Jun; 35(6):417-24. PubMed ID: 17849969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.